Vietnam MOH registration 220000018/PCBA-HD

Medgynax Contraceptive Tablet

VN: Viên đặt phụ khoa Medgynax

Vietnam·Risk Class TTBYT Loại A·Medgynax·Pulipha Pharmaceutical Corporation·Registered Feb 15, 2022

Registration details

Analysis ID: 220000018/PCBA-HD
Submission ID: 000.00.16.H23-220210-0001
Product Type: Medgynax

Company information

Manufacturer: Pulipha Pharmaceutical Corporation

Technical details

Intended Use: Supports in reducing the symptoms of vaginal itching, cervical inflammation, and vaginitis accompanied by leukorrhea due to bacterial or fungal infection; helps maintain the normal pH of the vagina, and enhances the ability of cells to regenerate; supports the treatment of vaginal dryness

Dates and status

Registration Date: Feb 15, 2022

About this record

Access comprehensive regulatory information for Medgynax Contraceptive Tablet in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại A medical device is registered under number 220000018/PCBA-HD and manufactured by Pulipha Pharmaceutical Corporation.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.